The SORL1 gene and convergent neural risk for Alzheimer's disease across the human lifespan

Molecular Psychiatry

Volumn 19, Issue 10, 2014, Pages 1125-1132

  Felsky, D ^a,b   Szeszko, P ^c,d,e   Yu, L ^f,g   Honer, W G ^h   De Jager, P L ^i,j   Schneider, J A ^g   Malhotra, A K ^c,d,e   Lencz, T ^c,d,e   Ikuta, T ^k   Pipitone, J ^a   Chakravarty, M M ^a,l   Lobaugh, N J ^a   Mulsant, B H ^a,b   Pollock, B G ^a,b   Kennedy, J L ^a,b   Bennett, D A ^f,g   Voineskos, A N ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ZUCKER HILLSIDE HOSPITAL   (United States)

^d FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^e DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^f RUSH UNIVERSITY MEDICAL CENTER   (United States)

^g RUSH UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^j BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^k UNIVERSITY OF MISSISSIPPI   (United States)

^l UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

Alzheimer's disease; Amyloid; Gene expression; Genetics; Neuroimaging; SORL1

Indexed keywords

AMYLOID; MESSENGER RNA; TAU PROTEIN; CARRIER PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; SORL1 PROTEIN, HUMAN;

ADOLESCENCE; AGE; AGED; ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; AUTOPSY; CHILDHOOD; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; FEMALE; FRACTIONAL ANISOTROPY; FRONTAL LOBE; GENE; GENE EXPRESSION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NERVOUS SYSTEM DEVELOPMENT; NEUROFIBRILLARY TANGLE; NEUROIMAGING; NEUROPATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SORTILIN LIKE RECEPTOR 1 GENE; TEMPORAL LOBE; VERY ELDERLY; WHITE MATTER; ADOLESCENT; ADULT; AGING; BRAIN; CHILD; GENETIC PREDISPOSITION; GENETICS; GROWTH, DEVELOPMENT AND AGING; INFANT; METABOLISM; MIDDLE AGED; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; BRAIN; CHILD; CHILD, PRESCHOOL; DIFFUSION TENSOR IMAGING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; LDL-RECEPTOR RELATED PROTEINS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; YOUNG ADULT;

EID: 84886135459     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2013.142     Document Type: Article

References (63)

1. Prince M, Jackson J. Alzheimer's Disease International World Alzheimer Report 2009. Alzheimer's Disease International, 2009 (cited 2012). Available from http://www.alz.co.uk/research/files/WorldAlzheimerReport.pdf.
2. Fox N. When, where, and how does Alzheimer's disease start? Lancet Neurol 2012; 11: 1017-1018.
3. Reiman EM, Quiroz YT, Fleisher AS, Chen K, Velez-Pardo C, Jimenez-Del-Rio M et al. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study. Lancet Neurol 2012; 11: 1048-1056.
4. Reiman EM, Langbaum JBS, Tariot PN. Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible. Biomark Med 2010; 4: 3-14.
5. Felsky D, Voineskos AN. APoe ε 4, aging, and effects on white matter across the adult life span. JAMA Psychiatry 2013; 70: 646-647.
6. Trachtenberg AJ, Filippini N, Mackay CE. The effects of APOE-ε4 on the BOLD response. Neurobiol Aging 2012; 33: 323-334.
7. Bertram L, Tanzi RE. The genetics of Alzheimer's disease. Prog Mol Biol Transl Sci 2012; 107: 79-100.
8. Hoe H-S, Rebeck GW. Functional interactions of APP with the apoE receptor family. J Neurochem 2008; 106: 2263-2271.
9. Andersen OM, Reiche J, Schmidt V, Gotthardt M, Spoelgen R, Behlke J et al. Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci USA 2005; 102: 13461-13466.
10. Offe K, Dodson SE, Shoemaker JT, Fritz JJ, Gearing M, Levey AI et al. The lipoprotein receptor LR11 regulates amyloid beta production and amyloid precursor protein traffic in endosomal compartments. J Neurosci 2006; 26: 1596-1603.
11. Capsoni S, Carlo A-S, Vignone D, Amato G, Criscuolo C, Willnow TE et al. SorLA deficiency dissects amyloid pathology from tau and cholinergic neurodegeneration in a mouse model of Alzheimer's disease. J Alzheimers Dis 2012; 33: 357-371.
12. Klinger SC, Glerup S, Raarup MK, Mari MC, Nyegaard M, Koster G et al. SorLA regulates the activity of lipoprotein lipase by intracellular trafficking. J Cell Sci 2011; 124: 1095-1105.
13. Lee JH, Barral S, Reitz C. The neuronal sortilin-related receptor gene SORL1 and late-onset Alzheimer's disease. Curr Neurol Neurosci Rep 2008; 8: 384-391.
14. Reitz C, Cheng R, Rogaeva E, Lee JH, Tokuhiro S, Zou F et al. Meta-analysis of the association between variants in SORL1 and Alzheimer disease. Arch Neurol 2011; 68: 99-106.
15. Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 2007; 39: 168-177.
16. Pottier C, Hannequin D, Coutant S, Rovelet-Lecrux A, Wallon D, Rousseau S et al. High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. Mol Psychiatr 2012; 17: 875-879.
17. Caglayan S, Bauerfeind A, Schmidt V, Carlo A-S, Prabakaran T, Hübner N et al. Identification of Alzheimer disease risk genotype that predicts efficiency of SORL1 expression in the brain. Arch Neurol 2012; 69: 373-379.
18. Grear KE, Ling I-F, Simpson JF, Furman JL, Simmons CR, Peterson SL et al. Expression of SORL1 and a novel SORL1 splice variant in normal and Alzheimers disease brain. Mol Neurodegener 2009; 4: 46.
19. Sager KL, Wuu J, Leurgans SE, Rees HD, Gearing M, Mufson EJ et al. Neuronal LR11/sorLA expression is reduced in mild cognitive impairment. Ann Neurol 2007; 62: 640-647.
20. Scherzer CR, Offe K, Gearing M, Rees HD, Fang G, Heilman CJ et al. Loss of apolipoprotein E receptor LR11 in Alzheimer disease. Arch Neurol 2004; 61: 1200-1205.
21. Cuenco KT, Lunetta KL, Baldwin CT, McKee AC, Guo J, Cupples LA et al. Association of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer disease. Arch Neurol 2008; 65: 1640-1648.
22. Bralten J, Arias-Vásquez A, Makkinje R, Veltman JA, Brunner HG, Fernández G et al. Association of the Alzheimer's gene SORL1 with hippocampal volume in young, healthy adults. Am J Psychiatry 2011; 168: 1083-1089.
23. Zhuang L, Sachdev PS, Trollor JN, Kochan NA, Reppermund S, Brodaty H et al. Microstructural white matter changes in cognitively normal individuals at risk of amnestic MCI. Neurology 2012; 79: 748-754.
24. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
25. Voineskos AN, O'Donnell LJ, Lobaugh NJ, Markant D, Ameis SH, Niethammer M et al. Quantitative examination of a novel clustering method using magnetic resonance diffusion tensor tractography. Neuroimage 2009; 45: 370-376.
26. Felsky D, Voineskos AN. APOE ε4, aging, and effects on white matter across the adult lifespan. Arch Gen Psychiatry 2013; 70: 646-647.
27. Felsky D, Voineskos AN, Lerch JP, Nazeri A, Shaikh SA, Rajji TK et al. Myelin-associated glycoprotein gene and brain morphometry in schizophrenia. Front Psychiatry 2012; 3: 40.
28. Westlye LT, Walhovd KB, Dale AM, Bjørnerud A, Due-Tønnessen P, Engvig A et al. Life-span changes of the human brain white matter: diffusion tensor imaging (DTI) and volumetry. Cereb Cortex 2010; 20: 2055-2068.
29. Peters BD, Szeszko PR, Radua J, Ikuta T, Gruner P, DeRosse P et al. White matter development in adolescence: diffusion tensor imaging and meta-analytic results. Schizophr Bull 2012; 38: 1308-1317.
30. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997; 36: 980-988.
31. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV-TR Axis I disorders, research version, non-patient edition. (SCID-I/NP) 2002.
32. Lipska BK, Deep-Soboslay A, Weickert CS, Hyde TM, Martin CE, Herman MM et al. Critical factors in gene expression in postmortem human brain: focus on studies in schizophrenia. Biological Psychiatry 2006; 60: 650-658.
33. Colantuoni C, Lipska BK, Ye T, Hyde TM, Tao R, Leek JT et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 2011; 478: 519-523.
34. Bennett DA, Schneider JA, Arvanitakis Z, Wilson RS. Overview and findings from the religious orders study. Curr Alzheimer Res 2012; 9: 628-645.
35. Bennett DA, Schneider JA, Buchman AS, Barnes LL, Boyle PA, Wilson RS. Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res 2012; 9: 646-663.
36. Bennett DA, Schneider JA, Aggarwal NT, Arvanitakis Z, Shah RC, Kelly JF et al. Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology 2006; 27: 169-176.
37. Bennett DA, Wilson RS, Boyle PA, Buchman AS, Schneider JA. Relation of neuropathology to cognition in persons without cognitive impairment. Ann Neurol 2012; 72: 599-609.
38. Chibnik LB, Shulman JM, Leurgans SE, Schneider JA, Wilson RS, Tran D et al. CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann Neurol 2011; 69: 560-569.
39. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 2006; 7: 3.
40. Kimura R, Yamamoto M, Morihara T, Akatsu H, Kudo T, Kamino K et al. SORL1 is genetically associated with Alzheimer disease in a Japanese population. Neurosci Lett 2009; 461: 177-180.
41. Tan EK, Lee J, Chen CP, Teo YY, Zhao Y, Lee WL. SORL1 haplotypes modulate risk of Alzheimer's disease in Chinese. Neurobiol Aging 2009; 30: 1048-1051.
42. Feulner TM, Laws SM, Friedrich P, Wagenpfeil S, Wurst SHR, Riehle C et al. Examination of the current top candidate genes for AD in a genome-wide association study. Mol Psychiatry 2010; 15: 756-766.
43. Meng Y, Lee JH, Cheng St R, George-Hyslop P, Mayeux R, Farrer LA. Association between SORL1 and Alzheimer's disease in a genome-wide study. Neuroreport 2007; 18: 1761-1764.
44. De Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S et al. MRI and CSF studies in the early diagnosis of Alzheimer's disease. J Intern Med 2004; 256: 205-223.
45. Jack Jr CR, Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 2004; 62: 591-600.
46. Karas GB, Scheltens P, Rombouts SARB, Visser PJ, van Schijndel RA, Fox NC et al. Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage 2004; 23: 708-716.
47. Huang H, Fan X, Weiner M, Martin-Cook K, Xiao G, Davis J et al. Distinctive disruption patterns of white matter tracts in Alzheimer's disease with full diffusion tensor characterization. Neurobiology Aging 2012; 33: 2029-2045.
48. Pievani M, Agosta F, Pagani E, Canu E, Sala S, Absinta M et al. Assessment of white matter tract damage in mild cognitive impairment and Alzheimer's disease. Hum Brain Map 2010; 31: 1862-1875.
49. Zhang Y, Schuff N, Du A-T, Rosen HJ, Kramer JH, Gorno-Tempini ML et al. White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI. Brain 2009; 132: 2579-2592.
50. Carmichael OT, Salloway S. Imaging markers of incipient dementia The white matter matters. Neurology 2012; 79: 726-727.
51. Hopkins RO, Beck CJ, Burnett DL, Weaver LK, Victoroff J, Bigler ED. Prevalence of white matter hyperintensities in a young healthy population. J Neuroimag 2006; 16: 243-251.
52. McCarthy JJ, Saith S, Linnertz C, Burke JR, Hulette CM, Welsh-Bohmer KA et al. The Alzheimer's associated 5′ region of the SORL1 gene cis regulates SORL1 transcripts expression. Neurobiol Aging 2012; 33: 1485 e1-8.
53. Schmidt V, Baum K, Lao A, Rateitschak K, Schmitz Y, Teichmann A et al. Quantitative modelling of amyloidogenic processing and its influence by SORLA in Alzheimer's disease. EMBO J 2012; 31: 187-200.
54. Ma Q-L, Galasko DR, Ringman JM, Vinters HV, Edland SD, Pomakian J et al. Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid. Arch Neurol 2009; 66: 448-457.
55. Dodson SE, Gearing M, Lippa CF, Montine TJ, Levey AI, Lah JJ. LR11/SorLA expression is reduced in sporadic Alzheimer disease but not in familial Alzheimer disease. J Neuropathol Exp Neurol 2006; 65: 866-872.
56. Cruchaga C, Kauwe JSK, Mayo K, Spiegel N, Bertelsen S, Nowotny P et al. SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease. PLoS Genet 2010; 6: e1001101.
57. Alexopoulos P, Guo L-H, Tsolakidou A, Kratzer M, Grimmer T, Westerteicher C et al. Interrelations between CSF soluble AbPPβ, amyloid-β 1-42, SORL1, and tau levels in Alzheimer's disease. J Alzheimers Dis 2012; 28: 543-552.
58. Bendlin BB, Carlsson CM, Johnson SC, Zetterberg H, Blennow K, Willette AA et al. CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease. PLoS One 2012; 7: e37720.
59. White T, Nelson M, Lim KO. Diffusion tensor imaging in psychiatric disorders. Top Magn Reson Imaging 2008; 19: 97-109.
60. Zhang Y, Schuff N, Jahng G-H, Bayne W, Mori S, Schad L et al. Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology 2007; 68: 13-19.
61. Larroza A, Moratal D, D'ocón Alcañiz V, Arana E. por la Alzheimer's Disease Neuroimaging Initiative. Tractography of the uncinate fasciculus and the posterior cingulate fasciculus in patients with mild cognitive impairment and Alzheimer disease. Neurologia advance online publication, 10 April 2013; pii: S0213-4853(13)00022-4; doi:10.1016/j.nrl.2013.02.002 (e-pub ahead of print).
62. Morikawa M, Kiuchi K, Taoka T, Nagauchi K, Kichikawa K, Kishimoto T. Uncinate fasciculus-correlated cognition in Alzheimer's disease: a diffusion tensor imaging study by tractography. Psychogeriatrics 2010; 10: 15-20.
63. Wang J-H, Lv P-Y, Wang H-B, Li Z-L, Li N, Sun Z-Y et al. Diffusion tensor imaging measures of normal appearing white matter in patients who are aging, or have amnestic mild cognitive impairment, or Alzheimer's disease. J Clin Neurosci 2013; 20: 1089-1094.